Florida surgeon general altered COVID-19 study findings

Florida Surgeon General Joseph Ladapo altered important findings in a COVID-19 study with the intent to spread misinformation about vaccine safety.

Ladapo personally made changes to a study about COVID-19 vaccines last year that suggested the vaccines had higher health risks for young men than the rest of the medical community established. The story was first reported by Politico. His changes, which were revealed by a public records request by the new outlet, specifically altered the risks of cardiac death to appear more severe than previous versions of the study, Politico reported. He later used the study to claim the Pfizer-BioNTech and Moderna vaccines were dangerous to young men.

Ladapo, a Harvard graduate who is also professor of medicine at the University of Florida, is a “well-known COVID-19 skeptic,” Politico said, and his alterations to the state-driven study reflected Gov. Ron Desantis’ beliefs that COVID-19 vaccines should not be mandatory. The revelations have caused some critics to argue Ladapo’s actions reflect political motivations rather than scientific concerns.

“The newly released draft of the eight-page study, provided by the Florida Department of Health, indicates that it initially stated that there was no significant risk associated with the Covid-19 vaccines for young men,” Politico reported. “But ‘Dr. L’s Edits,’ as the document is titled, reveal that Ladapo replaced that language to say that men between 18 and 39 years old are at high risk of heart illness from two Covid vaccines that use mRNA technology.”

Ladapo told Politico that revisions are a normal part of assessing surveillance data and he has the credentials to make such changes. Researchers say Ladapo’s edits removed a key analysis that contradicted his recommendation regarding vaccine safety.

Ladapo was appointed by DeSantis in September 2021 as Florida’s surgeon general, and he was criticized for being affiliated with America’s Frontline Doctors, a conservative group founded to fight COVID-19 restrictions by anti-vaccine advocate Simone Gold, according to Politico. He faced an internal complaint of “scientific fraud” for the changes he made to the draft study.

See the full story below.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.